COVID-19 and liver disease: An update-Reference-Cited by-同舟云学术

COVID-19 and liver disease: An update

Published:2020-10 Issue:8 Volume:43 Page:472-480
ISSN:2444-3824
Container-title:Gastroenterología y Hepatología (English Edition)
language:en
Short-container-title:Gastroenterología y Hepatología (English Edition)

Author:

Téllez Luis,Martín Mateos Rosa María

Publisher

Elsevier BV

Reference55 articles.

1. Clinical course and mortality risk of severe COVID-19;Weiss;Lancet.,2020

2. The resilience of the Spanish health system against the COVID-19 pandemic;Legido-Quigley;Lancet Public Heal.,2020

3. An interactive web-based dashboard to track COVID-19 in real time;Dong;Lancet Infect Dis.,2020

4. Ministerio de Sanidad. Actualización no 122. Enfermedad por el coronavirus (COVID-19). https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov-China/documentos/Actualizacion_122_COVID-19.pdf. s. f.:Accessed 13 June 2020.

5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor;Hoffmann;Cell.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CT attenuation values predict liver injury in COVID-19 patients;Egyptian Journal of Radiology and Nuclear Medicine;2024-08-09

2. Prevalence of HBV, HCV, HIV and Effect on Clinical Course in COVID-19 Patients;Online Türk Sağlık Bilimleri Dergisi;2024-03-11

3. Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system;PLOS ONE;2022-09-12

4. Impact of SARS-CoV-2 infection on liver disease;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2022-06-01

5. Infección por SARS-CoV-2 y su impacto en la enfermedad hepática;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2022-06-01